AgeX Therapeutics Inc. (AGE) shares are trading at lower $1.70.
To add more color to this target, the company’s high over the last year is $3.93 and the low is $0.67. Over the last 52 weeks, AGE is up 14.86% while the S&P 500 is up 7.73%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, AGE reported a profit of $0.38 million. AgeX Therapeutics Inc. also saw revenues increase to $0.41 million. In addition, AGE has free cash flow of -$4.32 million as of 06-2020. The company’s EBITDA came in at -$2.17 million which compares well with its peers.
AGE Return on Assets is -185.40%. All told, it is clear that, AGE needs to be on your watchlist.
Find out when AGE reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. AGE has a short ratio of 0.24 and outstanding shares of 37.66M.
AGE has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -0.31. AgeX Therapeutics Inc. AGE also noted assets of $4.76 million at the end of the last quarter. Investors should also keep an eye on sector updates as AGE has historically followed its peers on positive news.
All told, AgeX Therapeutics Inc. AGE has strung together solid data and demonstrated underlying fundamentals. At its current valuation, AGE represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
AgeX Therapeutics Inc. AGE is now commanding a market cap of 60.93M and a float of 21.05M. AGE is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of AGE stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in AGE, either long or short, and we have not been compensated for this article.